Xiaochen Qiao

Taiyuan, 030001, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 13 publications

Time-dependent evolution of osteosarcoma recurrence risk across clinical risk stratification and its prognostic value.

Time-dependent evolution of osteosarcoma recurrence risk across clinical risk stratification and its prognostic value.

Journal: American journal of cancer research

Published: April 06, 2026

Antitumor effect of alcohol extract of Isaria felina on H22 hepatocellular carcinoma in vitro and vivo.

Antitumor effect of alcohol extract of Isaria felina on H22 hepatocellular carcinoma in vitro and vivo.

Journal: Frontiers in oncology

Published: January 16, 2026

Exosomal miR-149 from human umbilical cord mesenchymal stem cells attenuates spinal cord injury-induced blood-spinal cord barrier disruption by suppressing the ET-1/PI3K/Akt signaling pathway.

Exosomal miR-149 from human umbilical cord mesenchymal stem cells attenuates spinal cord injury-induced blood-spinal cord barrier disruption by suppressing the ET-1/PI3K/Akt signaling pathway.

Journal: Stem cell research & therapy

Published: August 01, 2025

Therapeutic effects of Isaria felina on postmenopausal osteoporosis: modulation of gut microbiota, metabolites, and immune responses.

Therapeutic effects of Isaria felina on postmenopausal osteoporosis: modulation of gut microbiota, metabolites, and immune responses.

Journal: Frontiers in immunology

Published: October 09, 2024

DDTC-Cu(I) inhibits human osteosarcoma cells growth by repressing MET/PI3K/AKT signaling pathway.

DDTC-Cu(I) inhibits human osteosarcoma cells growth by repressing MET/PI3K/AKT signaling pathway.

Journal: Scientific reports

Published: June 26, 2024

Characterization of the gut microbiota and fecal metabolome in the osteosarcoma mouse model.

Characterization of the gut microbiota and fecal metabolome in the osteosarcoma mouse model.

Journal: Aging

Published: January 22, 2024

MiR-134-5p inhibits the malignant phenotypes of osteosarcoma via ITGB1/MMP2/PI3K/Akt pathway.

MiR-134-5p inhibits the malignant phenotypes of osteosarcoma via ITGB1/MMP2/PI3K/Akt pathway.

Journal: Cell death discovery

Published: October 28, 2023

Gut microbial community and fecal metabolomic signatures in different types of osteoporosis animal models.

Gut microbial community and fecal metabolomic signatures in different types of osteoporosis animal models.

Journal: Aging

Published: August 29, 2023

Cisplatin and doxorubicin chemotherapy alters gut microbiota in a murine osteosarcoma model.

Cisplatin and doxorubicin chemotherapy alters gut microbiota in a murine osteosarcoma model.

Journal: Aging

Published: August 11, 2023

Experimental research on spinal metastasis with mouse models.

Experimental research on spinal metastasis with mouse models.

Journal: Chinese medical journal

Published: March 11, 2023

Gut microbiota and fecal metabolic signatures in rat models of disuse-induced osteoporosis.

Gut microbiota and fecal metabolic signatures in rat models of disuse-induced osteoporosis.

Journal: Frontiers in cellular and infection microbiology

Published: August 14, 2022

Transcriptomics and metabolomics reveal changes in the regulatory mechanisms of osteosarcoma under different culture methods in vitro.

Transcriptomics and metabolomics reveal changes in the regulatory mechanisms of osteosarcoma under different culture methods in vitro.

Journal: BMC medical genomics

Published: May 23, 2022

Showing 1-12 of 13

Last Updated: 09/26/2026